Breakthrough trial aims to boost stroke recovery when time is critical

NCT ID NCT07347626

Summary

This study is testing whether adding a medication called eptifibatide helps people recover better after receiving standard clot-busting treatment for a stroke. It focuses on patients who get treatment 4.5 to 24 hours after symptoms begin and who aren't improving well. The main goal is to see if more patients can regain good function with minimal disability 90 days later.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ganzhou People's Hospital

    Ganzhou, Jiangxi, 341000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Affiliated Hospital of Jinggangshan University

    Ji’an, Jiangxi, 343000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Affiliated Hospital of Gannan Medical University

    Ganzhou, Jiangxi, 341000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Affiliated Hospital of Hainan Medical University

    Haikou, Hainan, 570100, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, 330006, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Xinqiao Hospital and The Second Affiliated Hospital

    Chongqing, Chongqing Municipality, 400000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.